Author

M. Kumari

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:drug response / drug discovery· 3 Organism:mouse· 3 Assay:proteomics· 3 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

H.-C. Wu· 3 shared F.-F. Hsu· 2 shared H.-T. Lin· 2 shared K.-H. Liang· 2 shared M.-H. Tao· 2 shared W.-Y. Chen· 2 shared Y.-C. Chou· 2 shared A. Diwan· 1 shared

Activity by Year

2021-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

H.-C. Wu

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

An Efficient Approach for SARS-CoV-2 Monoclonal Antibody Production via Modified mRNA-LNP Immunization

F.-F. Hsu, K.-H. Liang, M. Kumari, W. Y. Chen, H. T. Lin, C. M. Cheng, M.-H. Tao, H.-C. Wu

This study combines mRNA-LNP immunization with hybridoma fusion to produce SARS-CoV-2 monoclonal antibodies, showing improved antibody titers and cross-variant neutralization.

bioRxiv · Apr 20, 2022Immunology

Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice

R.-M. Lu, K.-H. Liang, H.-L. Chiang, F.-F. Hsu, H.-T. Lin, W.-Y. Chen, F.-Y. Ke, M. Kumari, Y.-C. Chou, H.-C. Wu

This paper develops broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 using mRNA-lipid nanoparticle immunization in mice, showing effectiveness against multiple variants.

bioRxiv · Apr 19, 2022Immunology

Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variants

I.-J. Lee, C.-P. Sun, P.-Y. Wu, Y.-H. Lan, I.-H. Wang, W.-C. Liu, S.-C. Tseng, S.-I. Tsung, Y.-C. Chou, M. Kumari, Y.-W. Chang, H.-F. Chen, Y.-S. Lin, T. -Y. Chen, C.-W. Chiu, , M.-H. Tao

This study evaluates Omicron-specific mRNA vaccines and finds they induce strong neutralizing antibodies against Omicron but not other variants, while bivalent vaccines show broader neutralizing activity.

bioRxiv · Jan 31, 2022Microbiology

TRAF2, an innate immune sensor, reciprocally regulates mitophagy and inflammation to maintain cardiac myocyte homeostasis.

X. Ma, D. R. Rawnsley, A. Kovacs, M. Islam, J. T. Murphy, C. Zhao, M. Kumari, L. M. Foroughi, H. Liu, K. Hyrc, S. Evans, B. A. French, K. B. Margulies, A. Javaheri, B. Razani, , A. Diwan

This study shows TRAF2 regulates mitophagy and inflammation in cardiac myocytes to prevent cell death and maintain homeostasis.

bioRxiv · Jun 12, 2021Cell Biology